The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign ...
Mar 24, 2022
0
2
Respiratory syncytial virus (RSV) is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes ...
Mar 14, 2022
0
55
A new study from Lund University in Sweden on how the Pfizer-BioNTech COVID-19 vaccine affects human liver cells under experimental conditions, has been viewed more than 800,000 times in just over a week. The results have ...
Mar 10, 2022
0
159
French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.
Feb 23, 2022
0
3
A new genomics study led by the University of Liverpool will help guide the development and use of vaccines against a globally leading cause of severe diarrhea in children: shigella.
Feb 1, 2022
0
40
As black-legged ticks crawl their way across Michigan, scientists hope a new vaccine in development could make their presence less menacing.
Jan 3, 2022
0
108
An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. ...
Dec 16, 2021
0
75
West African nations need to drastically ramp up their COVID-19 vaccination programmes by factor of 10 if they are to reach at least 60% coverage by 2022 and achieve the population level immunity needed to bring the pandemic ...
Dec 14, 2021
0
2
Africa is seeing a rise in deliveries of vaccine doses to the continent, but only one in four of its health workers has been fully vaccinated against COVID-19, the World Health Organization regional office said on Thursday.
Nov 25, 2021
0
1
Prince Charles praised Cambridge as a center of scientific collaboration Tuesday as the pharmaceutical company AstraZeneca opened a 1 billion-pound ($1.34 billion) research center, hoping to build on work in developing one ...
Nov 23, 2021
0
3
